- ICH GCP
- US Clinical Trials Registry
- Search trials
Søg i kliniske forsøg efter: PSMA therapy
I alt 51936 resultater
-
Fusion Pharmaceuticals Inc.RekrutteringMetastatisk kastrationsresistent prostatakræftForenede Stater
-
University of MiamiIkke rekrutterer endnuProstatakræft | Prostata Adenocarcinom | Hormonfølsom prostatakræftForenede Stater
-
University Hospital, EssenBristol-Myers Squibb; Advanced Accelerator ApplicationsIkke rekrutterer endnuMeget højrisiko prostatakarcinomTyskland
-
Peking University First HospitalIkke rekrutterer endnu
-
Novartis PharmaceuticalsIkke rekrutterer endnu
-
The First Affiliated Hospital of Xiamen UniversityRekrutteringMetastatisk kastrationsresistent prostatakræft, mCRPCKina
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC; Lantheus Medical ImagingIkke rekrutterer endnuMetastatisk nyrecellekarcinom | Metastatisk klarcellet nyrecellekarcinom
-
University Hospital, Basel, SwitzerlandIkke rekrutterer endnu
-
Rohan GarjeJanssen Scientific Affairs, LLCIkke rekrutterer endnuKastrationsresistent prostatakræft | Metastatisk prostatakræft | Metastatisk kastrationsresistent prostatakræftForenede Stater
-
University College, LondonNovartis; Cancer Research UK; Janssen Pharmaceutica NVIkke rekrutterer endnu
-
UNICANCERBayerIkke rekrutterer endnu
-
Central Hospital, Nancy, FranceIkke rekrutterer endnu
-
Erasmus Medical CenterRekrutteringProstatakræft MetastatiskHolland
-
Medical University of ViennaRekruttering
-
POINT Biopharma, a wholly owned subsidiary of Eli...Eli Lilly and CompanyRekrutteringProstatakræft | Biokemisk tilbagevendende prostatakarcinom | Metastatisk kastrationsresistent prostatakræftCanada
-
Medical University of ViennaRekruttering
-
Centre Georges Francois LeclercIkke rekrutterer endnuPatienter med metastatisk kastrationsresistent prostatakræft
-
University of Kansas Medical CenterNational Cancer Institute (NCI)Ikke rekrutterer endnuRelugolix i kombination med strålebehandling til behandling af patienter med højrisiko prostatakræftFase IV prostatakræft AJCC v8 | Stage IIC prostatakræft AJCC v8 | Fase III prostatakræft AJCC v8Forenede Stater
-
Emory UniversityNational Cancer Institute (NCI)RekrutteringBiokemisk tilbagevendende prostatakarcinom | Prostata AdenocarcinomForenede Stater
-
VA Office of Research and DevelopmentRekrutteringProstatakræftForenede Stater
-
Jonsson Comprehensive Cancer CenterJanssen Scientific Affairs, LLCRekrutteringProstata Adenocarcinom | Fase II prostatakræft AJCC v8 | Fase IIIA prostatakræft AJCC v8 | Stadie IIIB prostatakræft AJCC v8Forenede Stater
-
Centre Leon BerardRekrutteringMetastatisk klarcellet nyrecellekarcinomFrankrig
-
University of AlbertaRekruttering
-
Methodist Health SystemRekruttering
-
Novartis PharmaceuticalsRekrutteringMetastatisk kastrationsresistent prostatakræft (mCRPC)Frankrig
-
Novartis PharmaceuticalsRekrutteringOligometastatisk prostatacancer (OMPC)Japan, Singapore, Canada, Israel, Schweiz, Australien, Forenede Stater
-
OHSU Knight Cancer InstituteOregon Health and Science University; Progenics Pharmaceuticals, Inc.Ikke rekrutterer endnuProstata Adenocarcinom | Kastrationsresistent prostatakræft | Kastrationsfølsom prostatakræftForenede Stater
-
Erasmus Medical CenterDutch Cancer SocietyRekrutteringProstatiske neoplasmer, kastrationsresistenteHolland
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR)Ikke rekrutterer endnuKræft | Prostatakræft | Metastatisk kræft | Metastatisk prostatakræft
-
Istituto Scientifico Romagnolo per lo Studio e...Rekruttering
-
Novartis PharmaceuticalsRekrutteringProstatisk neoplasmaKorea, Republikken, Singapore, Forenede Stater, Canada, Polen, Spanien, Tjekkiet
-
BAMF HealthRekrutteringMetastatisk kastrationsresistent prostatakræftForenede Stater
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RekrutteringProstata Adenocarcinom | Stadie IIIB prostatakræft AJCC v8 | Stadie IIIC prostatakræft AJCC v8Forenede Stater
-
BayerRekrutteringBiokemisk tilbagevendende prostatakræftØstrig, Spanien, Forenede Stater, Australien, Brasilien, Frankrig, Tyskland, Taiwan, Danmark, Kina, Holland, Portugal, Japan, Canada, Finland, Italien, Ungarn, Det Forenede Kongerige, Polen, Israel, New Zealand, Sverige, Belgien, Tjekkiet
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationRekrutteringDiffust storcellet B-celle lymfomForenede Stater
-
Shanghai Unicar-Therapy Bio-medicine Technology...The First Affiliated Hospital of Soochow UniversityRekruttering
-
Novartis PharmaceuticalsRekrutteringMetastatisk kastrationsresistent prostatacancer (mCRPC)Kina
-
University of Wisconsin, MadisonRekruttering
-
Clarity Pharmaceuticals LtdRekrutteringProstatiske neoplasmer | KastrationsbestandigForenede Stater
-
National Cancer Institute (NCI)RekrutteringProstatiske neoplasmer | Prostatakræft | Prostata AdenocarcinomForenede Stater
-
Medical University of BialystokMedical Research Agency, PolandRekruttering
-
Cellbion Co., Ltd.Rekruttering
-
Shenzhen Geno-Immune Medical InstituteRekruttering
-
Shenzhen Geno-Immune Medical InstituteRekruttering
-
University of California, San FranciscoNational Cancer Institute (NCI); Prostate Cancer FoundationRekruttering
-
Jonsson Comprehensive Cancer CenterRekrutteringKastrationsresistent prostatakarcinom | Metastatisk prostatakarcinom | Stage IVA prostatakræft AJCC v8 | Stadie IVB prostatakræft AJCC v8 | Fase IV prostatakræft American Joint Committee on Cancer (AJCC) v8Forenede Stater
-
Lava TherapeuticsMerck Sharp & Dohme LLCRekrutteringMetastatisk kastrationsresistent prostatakræftForenede Stater, Spanien, Holland
-
Shanghai Zhongshan HospitalRekrutteringHelicobacter pylori infektionKina
-
Fusion Pharmaceuticals Inc.RekrutteringMetastatisk kastrationsresistent prostatakræftForenede Stater